ES2533129T3 - Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno - Google Patents

Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno Download PDF

Info

Publication number
ES2533129T3
ES2533129T3 ES13167541.5T ES13167541T ES2533129T3 ES 2533129 T3 ES2533129 T3 ES 2533129T3 ES 13167541 T ES13167541 T ES 13167541T ES 2533129 T3 ES2533129 T3 ES 2533129T3
Authority
ES
Spain
Prior art keywords
region
carbon
atom
group
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13167541.5T
Other languages
English (en)
Spanish (es)
Inventor
Tadaaki Ohgi
Hirotake Hayashi
Hisao SHIROHZU
Tomohiro HAMASAKI
Akihiro Itoh
Hiroshi Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bonac Corp
Original Assignee
Bonac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonac Corp filed Critical Bonac Corp
Application granted granted Critical
Publication of ES2533129T3 publication Critical patent/ES2533129T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3519—Fusion with another nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/50—Methods for regulating/modulating their activity
    • C12N2320/51—Methods for regulating/modulating their activity modulating the chemical stability, e.g. nuclease-resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES13167541.5T 2010-08-03 2011-07-28 Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno Active ES2533129T3 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP2010174915 2010-08-03
JP2010174915 2010-08-03
JP2010230806 2010-10-13
JP2010230806 2010-10-13
JP2010269823 2010-12-02
JP2010269823 2010-12-02
JP2011152381 2011-07-08
JP2011152381 2011-07-08

Publications (1)

Publication Number Publication Date
ES2533129T3 true ES2533129T3 (es) 2015-04-07

Family

ID=45559420

Family Applications (4)

Application Number Title Priority Date Filing Date
ES13167541.5T Active ES2533129T3 (es) 2010-08-03 2011-07-28 Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
ES13167536.5T Active ES2528285T3 (es) 2010-08-03 2011-07-28 Molécula de ácido nucleico monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
ES11748250.5T Active ES2443346T3 (es) 2010-08-03 2011-07-28 Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
ES13184178.5T Active ES2527660T3 (es) 2010-08-03 2011-07-28 Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES13167536.5T Active ES2528285T3 (es) 2010-08-03 2011-07-28 Molécula de ácido nucleico monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
ES11748250.5T Active ES2443346T3 (es) 2010-08-03 2011-07-28 Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
ES13184178.5T Active ES2527660T3 (es) 2010-08-03 2011-07-28 Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno

Country Status (9)

Country Link
EP (4) EP2436767B1 (enExample)
JP (3) JP4965745B2 (enExample)
KR (3) KR101849801B1 (enExample)
CN (3) CN104004018B (enExample)
DK (1) DK2674494T3 (enExample)
ES (4) ES2533129T3 (enExample)
PT (1) PT2674494E (enExample)
TW (2) TWI572716B (enExample)
WO (1) WO2012017919A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691782B2 (en) 2010-08-03 2014-04-08 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
WO2013077446A1 (ja) * 2011-11-26 2013-05-30 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
US9404108B2 (en) 2012-03-04 2016-08-02 Bonac Corporation Micro-RMA inhibitor
WO2013133393A1 (ja) * 2012-03-07 2013-09-12 学校法人東京医科大学 Ｖｅｇｆ遺伝子の発現抑制用一本鎖核酸分子
US20150105442A1 (en) * 2012-03-29 2015-04-16 Aqua Therapeutics Co., Ltd. Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid Molecule
US9663784B2 (en) 2012-05-26 2017-05-30 Bonac Corporation Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
US20160304866A1 (en) * 2013-09-27 2016-10-20 Aqua Therapeutics Co., Ltd. Drug for Disease Caused by Expression of Periostin Except Eye Disease, and Use Thereof
WO2015093495A1 (ja) * 2013-12-16 2015-06-25 株式会社ボナック ＴＧＦ－β１遺伝子発現制御のための一本鎖核酸分子
CN105899663B (zh) 2013-12-26 2019-07-26 学校法人东京医科大学 用于基因表达控制的人工模拟miRNA及其用途
CN106068324B (zh) * 2013-12-27 2020-12-29 株式会社博纳克 控制基因表达的人工匹配型miRNA及其用途
WO2015099188A1 (ja) * 2013-12-27 2015-07-02 株式会社ボナック 遺伝子発現制御のための人工マッチ型ｍｉＲＮＡおよびその用途
HK1244035A1 (en) * 2014-12-15 2018-07-27 Bonac Corporation Single-stranded nucleic acid molecule for inhibiting tgf- beta 1 expression
BR112017013664A2 (pt) * 2014-12-27 2018-03-13 Bonac Corporation mirna de tipo natural, composição, métodos para inibir expressão de um gene alvo e para tratar uma doença, e, ácido nucleico de fita simples.
HK1244031A1 (en) 2015-03-27 2018-07-27 Bonac Corporation Single-chain nucleic acid molecule having delivery function and gene expression control ability
JPWO2016167366A1 (ja) * 2015-04-17 2018-04-05 国立大学法人 東京大学 眼疾患治療剤
PL3369816T3 (pl) 2015-10-30 2024-07-22 Toray Industries, Inc. KOMPOZYCJA STABILNIE ZAWIERAJĄCA CZĄSTECZKĘ JEDNONICIOWEGO KWASU NUKLEINOWEGO, KTÓRA HAMUJE EKSPRESJĘ GENU TGF-β1
JP6634095B2 (ja) 2015-12-29 2020-01-22 国立大学法人北海道大学 プロレニン遺伝子またはプロレニン受容体遺伝子の発現を抑制する一本鎖核酸分子およびその用途
EP3409779A4 (en) * 2016-01-26 2019-07-03 Nissan Chemical Corporation Single-stranded oligonucleotide
US11518994B2 (en) 2016-01-30 2022-12-06 Bonac Corporation Artificial single guide RNA and use thereof
CN109071579B (zh) * 2016-04-26 2021-05-14 住友化学株式会社 单链核酸分子用单体的制造方法
MX2019009305A (es) 2017-02-06 2019-09-19 Nissan Chemical Corp Oligonucleotido de cadena simple.
JPWO2018182008A1 (ja) 2017-03-31 2020-02-06 株式会社ボナック 遺伝子発現制御機能を有する環状型核酸分子
JPWO2018199338A1 (ja) * 2017-04-27 2020-03-12 国立大学法人広島大学 Ｂ型肝炎治療用核酸分子
SG11201913541QA (en) * 2017-07-28 2020-02-27 Kyorin Pharmaceutical Co Ltd Therapeutic agent for fibrosis
US20210188895A1 (en) 2017-10-13 2021-06-24 Bonac Corporation Single-stranded nucleic acid molecule, and production method therefor
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
EP3770256A4 (en) 2018-03-20 2021-12-22 Tokyo Institute of Technology OLIGONUCLEOTIDE ANTISENS WITH REDUCED TOXICITY
US11920131B2 (en) 2018-03-30 2024-03-05 Toray Industries, Inc. Method of producing hairpin single-stranded RNA molecule
US20210115485A1 (en) 2018-03-30 2021-04-22 Sumitomo Chemical Company, Limited Method for producing single-strand rna
JP7405086B2 (ja) * 2018-10-02 2023-12-26 東レ株式会社 ヘアピン型一本鎖ｒｎａ分子の製造方法
JP7241098B2 (ja) 2019-01-25 2023-03-16 杏林製薬株式会社 線維症治療剤
WO2020202952A1 (ja) 2019-03-29 2020-10-08 住友化学株式会社 無機多孔質担体、及びこれを用いた核酸の製造方法
EP3950695A4 (en) 2019-03-29 2023-01-25 Sumitomo Chemical Company, Limited PROCEDURE FOR PRODUCTION OF RNA
WO2020202953A1 (ja) 2019-03-29 2020-10-08 住友化学株式会社 無機多孔質担体、及びこれを用いた核酸の製造方法
WO2020202951A1 (ja) 2019-03-29 2020-10-08 住友化学株式会社 無機多孔質担体、及びこれを用いた核酸の製造方法
US12371451B2 (en) 2019-03-29 2025-07-29 Sumitomo Chemical Company, Limited Inorganic porous carrier and method for producing nucleic acids using same
JP7640461B2 (ja) 2019-10-11 2025-03-05 住友化学株式会社 核酸オリゴマーの製造方法
CN115003682A (zh) 2020-01-29 2022-09-02 住友化学株式会社 核酸寡聚物的制造方法
US12391716B2 (en) 2020-01-29 2025-08-19 Sumitomo Chemical Company, Limited Process of preparing nucleic acid oligomer
WO2021193954A1 (ja) 2020-03-27 2021-09-30 住友化学株式会社 核酸オリゴマーの製造方法
US20230256425A1 (en) 2020-05-13 2023-08-17 Sumitomo Chemical Company, Limited Inorganic porous substrate, inorganic porous support, and nucleic acid production method
EP4180442A4 (en) 2020-07-09 2025-05-14 Sumitomo Chemical Company, Limited METHOD FOR PRODUCING A NUCLEIC ACID OLIGOMER
US20240051986A1 (en) * 2020-09-24 2024-02-15 Sumitomo Chemical Company, Limited Method for producing nucleic acid oligomer
EP4410770A1 (en) 2021-09-28 2024-08-07 Sumitomo Chemical Company, Limited Production method for purified dichloroacetic acid
EP4488282A4 (en) 2022-03-23 2025-11-19 Sumitomo Chemical Co PROCESS FOR THE PRODUCTION OF NUCLEIC ACID OLIGOMERS

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
GB9621367D0 (en) * 1996-10-14 1996-12-04 Isis Innovation Chiral peptide nucleic acids
US6509323B1 (en) 1998-07-01 2003-01-21 California Institute Of Technology Linear cyclodextrin copolymers
WO2005019453A2 (en) * 2001-05-18 2005-03-03 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
US6962906B2 (en) * 2000-03-14 2005-11-08 Active Motif Oligonucleotide analogues, methods of synthesis and methods of use
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
US20060111312A1 (en) * 2002-02-22 2006-05-25 The John Hopkins University Antigene locks and therapeutic uses thereof
US20040058886A1 (en) 2002-08-08 2004-03-25 Dharmacon, Inc. Short interfering RNAs having a hairpin structure containing a non-nucleotide loop
NL1022811C2 (nl) * 2003-02-28 2004-08-31 Fountain Patents B V Systeem en werkwijze voor opslag en transport van zeecontainers.
EP1608735A4 (en) * 2003-04-03 2008-11-05 Alnylam Pharmaceuticals RNAI CONJUGATES
JPWO2005030960A1 (ja) * 2003-09-30 2006-12-07 アンジェスＭｇ株式会社 ステイプル型オリゴヌクレオチドおよびそれからなる医薬
WO2006088490A2 (en) * 2004-06-30 2006-08-24 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a non-phosphate backbone linkage
WO2006074108A2 (en) * 2004-12-30 2006-07-13 Hauser Todd M Compositions and methods for modulating gene expression using self-protected oligonucleotides
PL2129680T3 (pl) * 2007-03-21 2015-10-30 Brookhaven Science Ass Llc Łączone kompozycje cząsteczek antysensownych o strukturze spinki do włosów oraz sposoby modulacji ekspresji
CN101889087B (zh) * 2007-11-29 2013-04-03 苏州瑞博生物技术有限公司 一种干扰靶基因表达的复合分子及其制备方法
CA2930393C (en) * 2007-12-04 2022-11-29 Alnylam Pharmaceuticals, Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
WO2009076321A2 (en) * 2007-12-07 2009-06-18 Halo-Bio Rnai Therapeutics Inc. Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides
JP2010174915A (ja) 2009-01-27 2010-08-12 Toyota Motor Corp 高圧ガスタンク
JP5449815B2 (ja) 2009-03-26 2014-03-19 住友化学株式会社 偏光板の製造方法
JP2010269823A (ja) 2009-05-21 2010-12-02 British American Tobacco Japan Kk 喫煙品用容器
JP2011152381A (ja) 2010-01-25 2011-08-11 Ucom:Kk 箸置き

Also Published As

Publication number Publication date
TW201615835A (zh) 2016-05-01
DK2674494T3 (en) 2015-02-23
KR101894701B1 (ko) 2018-09-04
EP2639307A8 (en) 2014-04-30
JP2013138681A (ja) 2013-07-18
WO2012017919A1 (ja) 2012-02-09
JP4965745B2 (ja) 2012-07-04
ES2528285T3 (es) 2015-02-06
JP2013034470A (ja) 2013-02-21
EP2628801B1 (en) 2015-01-07
EP2639307A3 (en) 2014-02-05
EP2436767A4 (en) 2012-05-09
EP2639307A2 (en) 2013-09-18
EP2674494B1 (en) 2014-12-17
TWI572716B (zh) 2017-03-01
JPWO2012017919A1 (ja) 2013-10-03
KR101894702B1 (ko) 2018-09-04
HK1200460A1 (en) 2015-08-07
ES2527660T3 (es) 2015-01-28
PT2674494E (pt) 2015-02-27
TWI515294B (zh) 2016-01-01
CN104059911A (zh) 2014-09-24
CN103052711A (zh) 2013-04-17
JP5261677B2 (ja) 2013-08-14
KR20180040728A (ko) 2018-04-20
KR101849801B1 (ko) 2018-04-17
CN103052711B (zh) 2016-08-03
TW201219570A (en) 2012-05-16
EP2639307B1 (en) 2015-03-04
JP5555346B2 (ja) 2014-07-23
HK1189910A1 (en) 2014-06-20
EP2436767A1 (en) 2012-04-04
CN104059911B (zh) 2017-01-04
CN104004018A (zh) 2014-08-27
EP2436767B1 (en) 2013-11-20
EP2628801A1 (en) 2013-08-21
KR20130095738A (ko) 2013-08-28
EP2674494A1 (en) 2013-12-18
KR20180040727A (ko) 2018-04-20
CN104004018B (zh) 2017-01-04
ES2443346T3 (es) 2014-02-19

Similar Documents

Publication Publication Date Title
ES2533129T3 (es) Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
EP2801617B1 (en) Single-stranded nucleic acid molecule having amino acid backbone
ES2550487T3 (es) Molécula de ácido nucleico monocatenario para controlar la expresión génica
US20130236968A1 (en) Multifunctional copolymers for nucleic acid delivery
EP3696269A1 (en) Single-stranded nucleic acid molecule, and production method therefor
AU2018247925A1 (en) Products and compositions
ES2936109T3 (es) Inhibición de TMPRSS6 mediada por interferencia de ARN
EP3406730A1 (en) Novel single chemical entities and methods for delivery of oligonucleotides
US10238752B2 (en) Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
US20220290143A1 (en) Products and compositions
JP6602847B2 (ja) デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子
CA2868716A1 (en) Nucleic acid molecule capable of inhibiting expression of periostin gene, method for inhibiting expression of periostin gene, and use of said nucleic acid molecule
WO2013133393A1 (ja) Ｖｅｇｆ遺伝子の発現抑制用一本鎖核酸分子
JP7427227B2 (ja) 腫瘍細胞の生存を低下させるｋｒａｓアンチセンスオリゴヌクレオチド及びその用途
WO2021132648A1 (ja) Ｒｅｃｑｌの発現を阻害するアンチセンスオリゴヌクレオチド及びその用途
EP3047852A1 (en) Drug for disease caused by expression of periostin except eye disease, and use thereof
EP3235906B1 (en) Single-stranded nucleic acid molecule for inhibiting tgf- beta 1 expression
CA3057565C (en) Products and compositions
WO2021132660A1 (ja) ＴＧＦ－β１遺伝子の発現を抑制する一本鎖核酸分子
JP2021112174A (ja) 腫瘍細胞の生存を低下させるｄｆｆａアンチセンスオリゴヌクレオチド及びその用途
JP2014140341A (ja) Ｒｐｎ２遺伝子の発現抑制用核酸分子、ｒｐｎ２遺伝子の発現抑制方法、およびその用途
HK40048015B (zh) 用於抑制tmprss6表达的核酸和铁螯合剂
HK1189910B (en) Single-stranded rna molecule having nitrogen-containing alicyclic skeleton